SEB Läkemedelsfond D
Equity fund
No data to display ...
1 year
USA
Largest region
No data to display ...
Risk
Annual costs
Morningstar
Partial
Sustainability
Development
Last 5 years
Description
- N/A
Investment horizon
- SEB Läkemedelsfond D is a Equity fund. This mutual fund type is suitable for those who plan to save for at least 6 years.
Characteristics
- Minimum amount
- Sharpe 3 years
- Price/NAV
21 Oct 2025
- Start date04 Sept 2025
- ISINSE0024788749
Risk
- Unknown
Morningstar rating
- The Morningstar Rating is an objective standard that tells us how well a fund has done compared to similar funds. If a fund performs better than other funds it is compared with, it receives a high rating. Correspondingly, a fund receives a low rating if it performs worse than similar funds.
Sustainability
- SustainabilityPartial
Annual cost
- Ongoing costs
Includes management fees of 1,50 %
- Platform fee
- Kickback fee
- Annual running costs
Other costs
- Performance-based fee
- Transaction costs
Costs for any currency exchanges are not included.
Allocation
- Stocks 99%Interest 1%
Portfolio
Shows the fund's largest investments.
- Eli Lilly and Co9.5%
- AstraZeneca PLC6.0%
- Thermo Fisher Scientific Inc4.6%
- Merck & Co Inc4.6%
- Novo Nordisk AS Class B4.0%
- UnitedHealth Group Inc3.8%
- UCB SA3.1%
- Boston Scientific Corp2.9%
- Intuitive Surgical Inc2.7%
- Gilead Sciences Inc2.6%